Presymptomatic detection of prions in blood

Science

Volumn 313, Issue 5783, 2006, Pages 92-94

  Saá, Paula ^a,b   Castilla, Joaquín ^a   Soto, Claudio ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL ENGINEERING; BIOCHEMISTRY; BIODIVERSITY; BRAIN; DIAGNOSIS; DISEASE CONTROL; PROTEINS;

INFECTIOUS AGENT; PRESYMPTOMATIC DETECTION; PRIONS; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSE);

BLOOD;

PRION PROTEIN;

BLOOD; DISEASE SPREAD; INCUBATION; INFECTIOUS DISEASE; PRION DISEASE; PROTEIN; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; HAMSTER; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCRAPIE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; CREUTZFELDT-JAKOB SYNDROME; CRICETINAE; HUMANS; LYMPHOCYTES; LYMPHOID TISSUE; MESOCRICETUS; PROTEIN FOLDING; PRPSC PROTEINS; SCRAPIE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

ANIMALIA; CRICETINAE; PRIONS (INFECTIVE AGENTS);

EID: 33745879463     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1129051     Document Type: Article

References (28)

1. S. B. Prusiner, Proc. Natl Acad. Sci. U.S.A 95, 13363 (1998).
2. S. N. Cousens, E. Vynnycky, M. Zeidler, R. G. Will, R. G. Smith, Nature 385, 197 (1997).
3. J. Collinge, Lancer 354, 317 (1999).
4. M. E. Bruce et al., Nature 389, 498 (1997).
5. R. Bradley, P. P. Liberski, Folia Neuropathol. 42 (suppL A), 55 (2004).
6. C. A. Llewelyn et al., Lancet 363, 417 (2004).
7. A. H. Peden, M. W. Head, D. L. Ritchie, J. E. Bell, ]. W. Ironside, Lancet 364, 527 (2004).
8. Q. Schiermeier, Nature 409, 658 (2001).
9. C. Soto, Nat. Rev. Microbiol. 2, 809 (2004).
10. L. Ingrosso, V. Vetrugno, F. Cardone, M. Pocchiari, Trends Mol. Med. 8, 273 (2002).
11. P. Brown, L. Cervenakova, H. Diringer, J. Lab. Clin. Med. 137, 5 (2001).
12. F. Houston, J. D. Foster, A. Chong, N. Hunter, C. J. Bostock, Lancet 356, 999 (2000).
13. J. Castilla, P. Saa, C. Soto, Nat. Med. 11, 982 (2005).
14. G. P. Saborio, B. Permanne, C. Soto, Nature 411, 810 (2001).
15. C. Soto, G. P. Saborio, L. Anderes, Trends Neurosci. 25, 390 (2002).
16. J. R. Silveira et al., Nature 437, 257 (2005).
17. R. H. Kimberlin, C. A. Walker, J. Comp. Pathol. 89, 551 (1979).
18. M. Glatzel, A. Aguzzi, Microbes Infect. 2, 613 (2000).
19. R. H. Kimberlin, C. A. Walker, J. Gen. Virol. 67, 255 (1986).
20. C. Soto et al., FEBS Lett. 579, 638 (2005).
21. J. Castilla, C. Hetz, C. Soto, Curr. Mol. Med. 4, 397 (2004).
22. W. A. Banks, J. Neurovirol. 5, 538 (1999).
23. P. Brown, Vox Sang. 89, 63 (2005).
24. N. Hunter et al., J. Gen. Virol. 83, 2897 (2002).
25. N. Hunter, Br. Med. Bull. 66, 171 (2003).
26. M. T. Bishop et al., Lancet Neurol. 5, 393 (2006).
27. J. W. Ironside, Haemophilia 12, 8 (2006).
28. This research was supported in part by NIH grants AG0224642 and NS049173.